Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Book

Polypharmacy

In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan.
.
Affiliations
Free Books & Documents
Book

Polypharmacy

Dona Varghese et al.
Free Books & Documents

Excerpt

The term polypharmacy was used over one and a half centuries ago to refer to issues related to multiple-drug consumption and excessive use of drugs. Since then, it has evolved with different meanings and situations, including but not limited to "unnecessary drug use" and "medication use without indication." Based on the review of current data, the use of 5 or more medications is an acceptable definition of polypharmacy. This cut-off point of 5 drugs is associated with the risk of adverse outcomes such as falls, frailty, disability, and mortality in older adults.

The World Health Organization suggests that while the definition is numerical, the emphasis should be on evidence-based practice and the goal of reducing inappropriate polypharmacy. The United States has one of the world's highest medication rates per capita. Management of polypharmacy is a challenge for all healthcare providers. Hence, this article will review strategies to reduce polypharmacy and skills to improve medication use management.

PubMed Disclaimer

Conflict of interest statement

Disclosure: Dona Varghese declares no relevant financial relationships with ineligible companies.

Disclosure: Cecilia Ishida declares no relevant financial relationships with ineligible companies.

Disclosure: Preeti Patel declares no relevant financial relationships with ineligible companies.

Disclosure: Hayas Haseer Koya declares no relevant financial relationships with ineligible companies.

References

    1. Masnoon N, Shakib S, Kalisch-Ellett L, Caughey GE. What is polypharmacy? A systematic review of definitions. BMC Geriatr. 2017 Oct 10;17(1):230. - PMC - PubMed
    1. Antimisiaris D, Cutler T. Managing Polypharmacy in the 15-Minute Office Visit. Prim Care. 2017 Sep;44(3):413-428. - PubMed
    1. Hughes C. Appropriate and inappropriate polypharmacy-Choosing the right strategy. Br J Clin Pharmacol. 2021 Jan;87(1):84-86. - PubMed
    1. Hosseini SR, Zabihi A, Jafarian Amiri SR, Bijani A. Polypharmacy among the Elderly. J Midlife Health. 2018 Apr-Jun;9(2):97-103. - PMC - PubMed
    1. von Buedingen F, Hammer MS, Meid AD, Müller WE, Gerlach FM, Muth C. Changes in prescribed medicines in older patients with multimorbidity and polypharmacy in general practice. BMC Fam Pract. 2018 Jul 28;19(1):131. - PMC - PubMed

Publication types

LinkOut - more resources